Kidney Protection by a Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor for a Mouse Model of Alport Syndrome

被引：0

作者：

Horizono, Jun ^{[1
]}

Kaseda, Shota ^{[1
]}

Sannomiya, Yuya ^{[1
]}

Suico, Mary Ann ^{[1
]}

Fukiya, Hirohiko ^{[2
]}

Sunamoto, Hidetoshi ^{[2
]}

Watanabe, Hiroshi ^{[3
]}

Nakano, Takehiro ^{[3
]}

Tokumaru, Kai ^{[3
]}

Davenport, John Bernard

John, Bernard ^{[4
]}

Shuto, Tsuyoshi ^{[1
]}

Lennon, Rachel

Onuma, Kazuhiro ^{[2
]}

Kai, Hirofumi ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Kumamoto, Japan

[2] UBE Corp, Pharmaceut Res Lab, Yamaguchi, Japan

[3] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto, Japan

[4] Univ Manchester, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期

关键词：

D O I：

10.1681/ASN.2024x8p67yq0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-PO640

引用

页数：2

共 50 条

[1] Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model
Kaseda, Shota
Sannomiya, Yuya
Horizono, Jun
Kuwazuru, Jun
Suico, Mary Ann
Ogi, Sayaka
Sasaki, Ryoko
Sunamoto, Hidetoshi
Fukiya, Hirohiko
Nishiyama, Hayato
Kamura, Misato
Niinou, Saki
Koyama, Yuimi
Nara, Futoshi
Shuto, Tsuyoshi
Onuma, Kazuhiro
Kai, Hirofumi
KIDNEY360, 2022, 3 (04): : 687 - 699
[2] Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction
Aparici, Monica
Bravo, Monica
Calama, Elena
Garcia-Gonzalez, Vicente
Domenech, Teresa
Cordoba, Monica
Roger, Ines
Cortijo, Julio
Gongora-Benitez, Miriam
Paradis-Bas, Marta
Collins, Barry
Davis, Andrew M.
Albericio, Fernando
Puig, Carlos
BIOCHEMICAL PHARMACOLOGY, 2022, 204
[3] Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction
Hancock, Rowena
Bertrand, Helene C.
Tsujita, Tadayuki
Naz, Shama
El-Bakry, Ayman
Laoruchupong, Jitnueng
Hayes, John D.
Wells, Geoff
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (02) : 444 - 451
[4] Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
Mou, Yi
Wen, Shuai
Li, Yu-Xiu
Gao, Xin-Xing
Zhang, Xin
Jiang, Zheng-Yu
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 202
[5] Development of Novel Inhibitors for Keap1-Nrf2 and Keap1-P62 Protein-Protein Interaction
Yasuda, Daisuke
Yuasa, Akihiro
Nakajima, Mao
Yoshida, Taketo
Obata, Rika
Takahashi, Kyoko
Ohe, Tomoyuki
Ichimura, Yoshinobu
Komatsu, Masaaki
Yamamoto, Masayuki
Imamura, Riyo
Kojima, Hirotatsu
Okabe, Takayoshi
Nagano, Tetsuo
Mashino, Tadahiko
FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S76 - S76
[6] Hit-to-Lead in Academia: Discovery of a Protein-Protein Interaction Inhibitor of Keap1-Nrf2
Yasuda, Daisuke
Obata, Rika
Takahashi, Kyoko
Ohe, Tomoyuki
Mashino, Tadahiko
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (08): : 1059 - 1065
[7] Novel Keap-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates the Severity of Experimental Alport Syndrome
Kaseda, Shota
Suico, Mary Ann
Ogi, Sayaka
Sunamoto, Hidetoshi
Fukiya, Hirohiko
Nara, Futoshi
Shuto, Tsuyoshi
Onuma, Kazuhiro
Kai, Hirofumi
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 418 - 418
[8] Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction
Lee, Sumi
Hu, Longqin
MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (05) : 846 - 867
[9] Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
Wells, Geoff
BIOCHEMICAL SOCIETY TRANSACTIONS, 2015, 43 : 674 - 679
[10] Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction
Hu, Longqin
Magesh, Sadagopan
Chen, Lin
Wang, Lili
Lewis, Timothy A.
Chen, Yu
Khodier, Carol
Inoyama, Daigo
Beamer, Lesa J.
Emge, Thomas J.
Shen, Jian
Kerrigan, John E.
Ah-Ng Tony Kong
Dandapani, Sivaraman
Palmer, Michelle
Schreiber, Stuart L.
Munoz, Benito
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 3039 - 3043

← 1 2 3 4 5 →